Boiron Celebrates 40 Years in the U.S., Continues to Lead in Homeopathic Medicines

Boiron

NEWTOWN SQUARE, PA — Boiron, a leading manufacturer of homeopathic medicines, is marking its 40th anniversary in the United States. The company, which originated in France over 90 years ago, has grown to become one of the largest over-the-counter pharmaceutical companies in France and a global leader in homeopathic remedies.

Boiron was established in the U.S. in 1983 with a subsidiary headquarters in suburban Philadelphia, followed by a branch in Simi Valley, California in 1989. Today, it boasts 23 subsidiaries and distribution in more than 50 countries, offering a wide range of products such as analgesics, cough and cold remedies, first aid supplies, baby and children’s health products, eye care, and personal care items.

In the U.S., Boiron is particularly known for its top-selling flu medicine, Oscillococcinum®, and the Arnicare® line of pain relievers. These products are readily available online, in pharmacies, and at natural product stores nationwide.

Janick Boudazin, President and CEO of Boiron’s U.S. Subsidiary, reaffirmed the company’s commitment to improving quality of life through homeopathy. “As we celebrate our 40th anniversary, our mission remains the same,” he said.

Boudazin outlined Boiron’s future plans, which include continuing comprehensive educational efforts for both beginners and experts in homeopathy. This includes consumers, healthcare practitioners, pharmacists, retailers, and others. He emphasized that Boiron will stay committed to its holistic vision of health — healing without harm — and continue to offer superior homeopathic medicines.

He also pointed out Boiron’s respect for people and nature, which forms the basis of its philosophy. “Throughout our history, we have made it an economic and ethical priority to plant the seeds of homeopathy around the world,” Boudazin stated. “We will continue to advance homeopathy with a respectful and humane approach to medicine, along with the scientific rigor and manufacturing standards that guarantee high-quality homeopathic medicines.”

READ:  Marinus Pharmaceuticals Continues Phase 3 Trial for Epilepticus Treatment Despite Setback

With increasing demand for homeopathic medicines, particularly among consumers seeking better-for-you options, Boudazin is optimistic about Boiron’s future in the U.S. “We are perfectly positioned for future growth in the marketplace,” he concluded.

For the latest news on everything happening in Chester County and the surrounding area, be sure to follow MyChesCo on Google News and Microsoft Start.